Skip to content

A multi-site trial of specialist palliative care in cystic fibrosis

Integrating specialist palliative care to improve care and reduce suffering: cystic fibrosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN53323164
Enrollment
264
Registered
2020-10-09
Start date
2020-11-01
Completion date
Unknown
Last updated
2023-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic fibrosis in adults Nutritional, Metabolic, Endocrine Cystic fibrosis

Interventions

Randomization to either quarterly visits and monthly calls with a palliative care nurse practitioner embedded in the cystic fibrosis (CF) clinic, or usual CF care. The visits will address physical and

Sponsors

Emory University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. English-speaking 2. Age =18 years 3. Palliative needs, as indicated by the following criteria: 3.1. =1 moderate or severe symptom (captured by the Integrated Palliative Outcomes Scale [IPOS]); OR 3.2. Reduced QoL (as captured by the IPOS); OR 3.3. =2 hospitalizations in the preceding year

Exclusion criteria

Exclusion criteria: 1. Post lung transplant 2. Patient does not receive primary CF care from the study site or intends to transfer primary CF care elsewhere over the next year 3. Received outpatient specialty palliative care within the past 12 months 4. Lack of reliable telephone or internet access 5. Active suicidal ideation

Design outcomes

Primary

MeasureTime frame
1. Patient quality of life, measured by FACIT-PAL at baseline and quarterly for 15 months (months 3, 6, 9, 12, 15) 2. Caregiver quality of life, measured by PROMIS Global 10 at baseline and quarterly for 15 months (months 3, 6, 9, 12, 15)

Secondary

MeasureTime frame
1. CF-specific quality of life measured by Cystic Fibrosis Questionnaire-Revised (collected monthly, primary endpoint 12 months, secondary endpoint 15 months) 2. Symptom burden measured by Memorial Symptom Assessment Scale-CF (collected monthly, primary endpoint 12 months, secondary endpoint 15 months) 3. Psychological distress measured by Hospital Anxiety and Depression Scale (HADS) (collected monthly, primary endpoint 12 months, secondary endpoint 15 months) 4. Coping measured by Brief COPE (collected monthly, primary endpoint 12 months, secondary endpoint 15 months) 5. Satisfaction with care measured by FAMCARE-16 (collected monthly, primary endpoint 12 months, secondary endpoint 15 months) 6. Healthcare utilization measured by emergency department visits, inpatient hospitalization, unplanned outpatient visits, vital status (baseline and 15 months) 7. Advance care planning measured by presence of documentation of discussion of care wishes or signed ACP documents (baseline and 15 months) 8. Caregiver burden measured by Zarit Burden Interview (collected monthly, primary endpoint 12 months, secondary endpoint 15 months)

Countries

Canada, United States of America

Contacts

Public ContactJane Lowers
jlowers@emory.edu+1 (0)4152798917

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 11, 2026